PCOS and Low Progesterone: Why It Happens and What It Means

Low progesterone gets blamed for a long list of things: irregular periods, spotting, poor sleep, mood swings, a cycle that never seems to settle. What rarely comes with that explanation is why progesterone is low in the first place, and for women with PCOS the answer usually begins with ovulation.

Most of your progesterone is made after an egg has been released. In a cycle where that doesn’t happen, there’s very little to measure, so a low result is often a clue about ovulation more than a hormone shortage in its own right. What it means for your periods, your uterine lining, and fertility is less clear-cut than most posts suggest, and so is what’s worth doing about it.

Where progesterone comes from

Progesterone is made mainly by the corpus luteum, a temporary structure that forms from the follicle after it releases an egg. Levels climb after ovulation, peak about six to eight days later, and keep the uterine lining stable. If there’s no pregnancy, they fall and your period begins. The stretch between ovulation and your next period is called the luteal phase, and we cover the whole cycle in our article on why you're not ovulating with PCOS.

Why progesterone is low with PCOS

Usually, it’s a result of not ovulating

In PCOS, follicles often start to grow and then stall, so no egg is released. No ovulation means no corpus luteum, and no corpus luteum means very little progesterone. Low progesterone and ovulation are closely tied, but the link runs mostly one way: low progesterone is a common consequence of anovulation rather than the reason follicles stall, so topping it up doesn’t touch the underlying problem.

A low result doesn’t always mean you aren’t ovulating, though. Progesterone levels in PCOS can also look low because the blood was drawn at the wrong point in the cycle, or because you caught a normal dip. Progesterone is released in pulses and can swing as much as eightfold within about 90 minutes, even in women who ovulate, so ASRM advises measuring it about a week before your expected period instead of on a fixed cycle day. A level above 3 ng/mL at that point counts as presumptive evidence of recent ovulation. That’s all it shows. It doesn’t make progesterone “optimal” or the luteal phase healthy, and no single threshold does.

Can it be low when you do ovulate?

It’s possible, though harder to pin down than most online sources imply. The idea is called luteal phase deficiency, usually defined as a luteal phase of 10 days or fewer. PCOS is one of several associated conditions, along with thyroid problems, high prolactin, and major weight changes, though studies define it in different ways.

Healthy cycles vary a lot. Among women who ovulate, mid-luteal progesterone falls below 5 ng/mL in roughly 8% of cycles and below 10 ng/mL in about 31%, and no level defines normal luteal function. ASRM says luteal phase deficiency hasn’t been proven to be an independent cause of infertility or recurrent pregnancy loss, and no test for it has proven reliable. One low-ish value in a cycle where you ovulated isn’t a diagnosis.

If your result comes back low

Progesterone testing with PCOS is easy to misread, so a few questions help put a flagged result in context:

• When was it drawn? If your cycles are long or unpredictable, a fixed-day test, such as day 21, may simply have come too early.
• Were you using hormonal birth control? Methods that suppress ovulation keep progesterone low, so a low level is expected.
• Does your cycle history already answer the question? According to ASRM, a history of very infrequent or absent periods is by itself enough to conclude that ovulation isn’t happening regularly, so the test may add little.
• Does it need repeating? A clinician may repeat it or weigh it against the pattern of your cycles instead of relying on one number.

What low progesterone means for you

Your cycle and bleeding

Without progesterone, estrogen keeps building the uterine lining with nothing to balance it, which clinicians call unopposed estrogen. The lining eventually sheds on its own schedule, and the bleeding can be irregular, unpredictable, and often heavy or prolonged, as StatPearls explains in its overview of anovulatory bleeding. Both the low progesterone and the irregular periods trace back to anovulation, and the missing progesterone is part of why the bleeding behaves the way it does. A period alone doesn’t prove you ovulated.

Your uterine lining

When ovulation is rare, the lining can build up for long stretches. The international guideline (PCOS is now also called PMOS, and both names are in use) notes that women with PCOS have a markedly higher risk of endometrial hyperplasia, an overgrowth of the lining, and of endometrial cancer, while stressing that the overall chance of cancer is low and routine screening isn’t recommended. Long-standing untreated absent periods add to the risk, and protective strategies include regular cycles, regular progestogen therapy (progestogen is the umbrella term for progesterone and its synthetic versions, called progestins), and weight management where relevant. Heavy or prolonged bleeding deserves evaluation.

Fertility and pregnancy

If you want to conceive, the main hurdle is usually ovulation itself. In natural cycles, ASRM finds no evidence that progesterone improves fertility or treats luteal phase deficiency, and no evidence supporting checking progesterone in an unassisted pregnancy and supplementing based on the number.

Progesterone does have a clear role in some fertility treatment. ASRM notes that it’s beneficial after various fertility treatments, and that ovulation induction with gonadotropins (injectable medications) can leave progesterone inadequate in the luteal phase. For women with PCOS having that treatment, ASRM says luteal support may help, but the evidence is insufficient to make a recommendation.

Early pregnancy is where recommendations differ most. For women with vaginal bleeding in early pregnancy or recurrent unexplained miscarriage, ASRM’s 2026 opinion on recurrent pregnancy loss says vaginal progesterone may be considered, using shared decision-making. The evidence is mixed. A large trial in women with unexplained recurrent miscarriage found no significant increase in live births when progesterone started after a positive pregnancy test, while a trial in women with early bleeding found a small, non-significant increase overall and a larger one (about 5 percentage points) among women who had miscarried before, a result ASRM says needs confirming. So routine progesterone isn’t established for every woman with a low result, and it isn’t ruled out in specific situations. If you’re pregnant or think you might be, talk with your clinician before taking any hormone.

What about mood, sleep, and other symptoms?

Online lists link low progesterone to anxiety, poor sleep, weight gain, and more. The effects with the clearest support are on your cycle and uterine lining, and the guideline doesn’t recommend progesterone for other symptoms. It does say that women with PCOS are more likely to experience depression and anxiety and recommends screening for both, so those symptoms deserve attention in their own right.

What can help with PCOS and low progesterone

What helps depends on your goal. Managing your cycle, protecting your lining, and restoring ovulation are three different jobs, and raising a progesterone number isn’t the same as any of them.

If you’re not trying to conceive

The guideline’s first-line option for irregular cycles and high-androgen features in PCOS is the combined pill. Combined hormonal methods (the pill, patch, and ring) work mainly by stopping ovulation, so they quiet the cycle rather than repair it. Other hormonal methods differ: the implant and injection mainly suppress ovulation, while progestin-only pills and hormonal IUDs lean more on thickening cervical mucus and changing the uterine lining, and ovulation can continue in some cycles.

Bleeding on these treatments needs careful reading. A withdrawal bleed is the bleed that follows stopping hormones, such as the hormone-free week of a combined pill or the end of a course of progestogen. It shows the lining built up and then shed. That happens within days of stopping the medicine whether or not you’ve ovulated, so a scheduled bleed isn’t evidence that you ovulated.

To protect the lining, clinicians may use regular progestogen therapy, including progestogen-only options, though the guideline notes evidence in PCOS is limited. These treatments manage bleeding and protect the lining. They don’t restore natural ovulation.

Can you raise progesterone naturally?

Not directly, because progesterone rises when you ovulate. The realistic way to improve low progesterone with PCOS is to support ovulation, and the evidence for doing that without medication is encouraging but limited. A September 2026 review in PLOS Medicine linked lifestyle programs to higher odds of regular cycles, but only a few studies measured it, and regular cycles aren’t the same as confirmed ovulation.

Healthy habits are recommended for everyone with PCOS, and where insulin resistance is present they’re part of the picture; our PCOS diet article and article on insulin resistance cover them. Metformin is an option for irregular cycles when the pill isn’t suitable, and the guideline notes that inositol offers limited clinical benefits, including for ovulation, which our inositol article explains. We didn’t find good evidence that any specific food or supplement raises progesterone in PCOS.

If you want to conceive

The guideline names letrozole as the first-line treatment for inducing ovulation when there’s no other fertility factor. Pregnancy should be ruled out before starting it, since the guideline says letrozole shouldn’t be given if there’s any possibility of an existing pregnancy. Dosing and monitoring belong with a fertility clinician.

Creams and compounded “bioidentical” hormones

Progesterone creams and compounded “bioidentical” products are often promoted as natural fixes for low progesterone. “Bioidentical” means chemically identical to the hormone your body makes. It isn’t a regulatory category, and FDA-approved prescription products can be bioidentical too. The real difference is how the finished product is reviewed. FDA-approved drugs are evaluated for safety, effectiveness, and quality before they’re sold. Compounded preparations, which pharmacies mix for individual prescriptions, are overseen mostly by state boards of pharmacy, with some FDA inspection, but they are not FDA-approved, which means the FDA doesn’t verify their safety, effectiveness, or quality before they’re marketed. The FDA says they should be used only when a patient’s needs can’t be met by an approved drug.

The National Academies concluded in 2020 that there isn’t enough evidence to support the routine clinical use of compounded bioidentical hormone therapy, and raised concerns about labeling and adverse-event reporting for these products. That work focused on menopause, as did a 2007 review in the Journal of General Internal Medicine that found no reliable data supporting claims that progesterone creams are safe, health-promoting tonics, and that traced the popular “estrogen dominance” idea to alternative-health books.

When the lining needs protecting, the guideline’s strategies involve prescribed progestogens, and FDA-approved options exist with labeled uses such as treating absent periods and abnormal uterine bleeding due to hormonal imbalance. A clinician can match the choice to your situation.

When to see a doctor

It’s worth getting evaluated if you have PCOS and low progesterone results alongside very infrequent or absent periods, heavy or prolonged bleeding, or plans to conceive. If a progesterone result concerns you, ask when in your cycle it was drawn and whether repeating it makes sense. PCOS isn’t the only possible cause of low progesterone: thyroid problems, high prolactin, intense exercise, and major weight changes can also play a role, so a clinician may check for them.

What to take from all this

Progesterone runs low in PCOS mainly because ovulation is infrequent, and the same missing ovulation explains much of the unpredictable bleeding. One result says little without knowing when it was drawn, whether you were using hormonal birth control, and what your cycles usually look like, and even a result above the ovulation threshold says nothing about how healthy the luteal phase is.

What to do about it depends on your goal. If you’re not trying to conceive, the priorities are a cycle you can predict and a uterine lining that sheds regularly or is protected. If you are, treatment aims at ovulation. In both cases, working out what’s happening with ovulation tends to be more useful than chasing a lab number with creams or supplements.

This article is for general education and does not replace advice from a qualified healthcare provider.

References

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463. Monash University guideline summary: https://www.monash.edu/__data/assets/pdf_file/0003/3371133/PCOS-Guideline-Summary-2023.pdf. Terminology update (June 2026): https://www.monash.edu/medicine/mchri/pcos/guideline
2. Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: new name to improve diagnosis and care of condition affecting 170 million women worldwide. Press release, 12 May 2026. https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
3. Practice Committee of the American Society for Reproductive Medicine. Diagnosis and treatment of luteal phase deficiency: a committee opinion. Fertil Steril. 2026;126:633-639. doi:10.1016/j.fertnstert.2026.06.014. https://www.asrm.org/practice-guidance/practice-committee-documents/diagnosis-and-treatment-of-luteal-phase-deciency-a-committee-opinion/
4. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2026 (replaces the 2021 version, Fertil Steril 2021;116:1255-1265). https://www.asrm.org/practice-guidance/practice-committee-documents/fertility-evaluation-of-infertile-women-a-committee-opinion-2026/
5. Practice Committee of the American Society for Reproductive Medicine. Recurrent pregnancy loss: a committee opinion. Fertil Steril. 2026;125:1023-1041. https://www.asrm.org/practice-guidance/practice-committee-documents/recurrent-pregnancy-loss-a-committee-opinion-2026/
6. Practice Committee of the American Society for Reproductive Medicine. Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion. Fertil Steril. 2020. https://www.asrm.org/practice-guidance/practice-committee-documents/use-of-exogenous-gonadotropins-for-ovulation-induction-in-anovulatory-women-a-committee-opinion-2020/
7. Anovulatory bleeding. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549773/
8. American College of Obstetricians and Gynecologists. Combined hormonal birth control: pill, patch, and ring (patient FAQ). https://www.acog.org/womens-health/faqs/combined-hormonal-birth-control-pill-patch-ring
9. Regidor PA. The clinical relevance of progestogens in hormonal contraception: present status and future developments. Oncotarget. 2018;9(77):34628-34638. doi:10.18632/oncotarget.26015
10. Pfizer Medical Information. PROVERA (medroxyprogesterone acetate) tablets: prescribing information revised March 2024. Indications and usage: https://www.pfizermedical.com/provera/indications-usage. Dosage and administration: https://www.pfizermedical.com/provera/dosage-admin
11. Olalere O, Koh MD, Crabb K, et al. The effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis. PLoS Med. 2026;23(9):e1004887. doi:10.1371/journal.pmed.1004887
12. National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington (DC): National Academies Press; 2020. doi:10.17226/25791. https://www.nap.edu/catalog/25791. News release, 1 July 2020: https://www.nationalacademies.org/news/prescribers-should-restrict-the-use-of-non-fda-approved-compounded-bioidentical-hormones-except-for-specific-medical-circumstances
13. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/compounding/compounding-and-fda-questions-and-answers
14. Fugh-Berman A, Bythrow J. Bioidentical hormones for menopausal hormone therapy: variation on a theme. J Gen Intern Med. 2007;22(7):1030-1034. doi:10.1007/s11606-007-0141-4